Description
NEW LUNAIR PLUS is a combination formulation designed to provide comprehensive relief from respiratory conditions such as allergic rhinitis and asthma. It contains Acebrophylline (200mg), Fexofenadine Hydrochloride (120mg), and Montelukast Sodium (10mg), each targeting different aspects of respiratory health.
Acebrophylline (200mg): Acebrophylline is a bronchodilator and anti-inflammatory agent that helps relax the muscles of the airways, making it easier to breathe. The sustained-release form of Acebrophylline ensures a prolonged effect, providing long-lasting relief from conditions like asthma and chronic obstructive pulmonary disease (COPD). It also helps reduce airway inflammation, a common issue in respiratory disorders.
Fexofenadine Hydrochloride (120mg): Fexofenadine is a non-sedating antihistamine used to treat allergy symptoms such as sneezing, runny nose, itchy eyes, and skin rashes associated with seasonal allergic rhinitis. Unlike first-generation antihistamines, Fexofenadine does not cause drowsiness, making it ideal for daily use without affecting alertness.
Montelukast Sodium (10mg): Montelukast is a leukotriene receptor antagonist that helps prevent asthma attacks and treats symptoms of allergic rhinitis. It works by blocking leukotrienes, chemicals that contribute to inflammation and bronchoconstriction, thus reducing swelling and narrowing of the airways, improving airflow, and decreasing allergy symptoms.
NEW LUNAIR PLUS provides a multi-faceted approach to managing respiratory conditions, addressing both allergic symptoms and inflammation, and helping improve lung function. It is particularly useful for patients with asthma, seasonal allergies, and chronic respiratory conditions, offering a combination of bronchodilation, anti-inflammatory effects, and antihistamine action.
